mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.1 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.1 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.065 |
0.1 |